Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 3,900 shares of the company’s stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00. Following the transaction, the chief executive officer owned 154,548 shares of the company’s stock, valued at approximately $2,346,038.64. This represents a 2.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total transaction of $12,168.00.

Afya Stock Down 1.3%

Shares of AFYA stock opened at $14.75 on Friday. The stock has a market cap of $1.38 billion, a P/E ratio of 10.10, a PEG ratio of 0.67 and a beta of 0.52. Afya Limited has a 52 week low of $13.00 and a 52 week high of $19.90. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21. The company’s fifty day simple moving average is $14.39 and its two-hundred day simple moving average is $14.74.

Afya (NASDAQ:AFYA) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. Afya had a return on equity of 18.77% and a net margin of 20.31%.The firm had revenue of $147.08 million during the quarter, compared to analyst estimates of $174.74 million. Analysts predict that Afya Limited will post 1.52 EPS for the current fiscal year.

Afya Dividend Announcement

The company also recently declared an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be issued a dividend of $0.656 per share. This represents a yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya’s dividend payout ratio (DPR) is currently 45.21%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Bank of America cut Afya from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a report on Friday, January 16th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reaffirmed a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Afya currently has a consensus rating of “Hold” and a consensus target price of $17.30.

Institutional Investors Weigh In On Afya

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Swedbank AB bought a new stake in shares of Afya in the 3rd quarter valued at approximately $1,092,000. SPX Gestao de Recursos Ltda bought a new position in shares of Afya during the 3rd quarter valued at approximately $2,895,000. Doma Perpetual Capital Management LLC increased its position in shares of Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after purchasing an additional 299,419 shares during the last quarter. Dodge & Cox raised its holdings in Afya by 12.8% during the 2nd quarter. Dodge & Cox now owns 35,262 shares of the company’s stock valued at $630,000 after buying an additional 4,000 shares during the period. Finally, Quadrature Capital Ltd purchased a new stake in Afya during the 2nd quarter valued at $181,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.